Baylor Scott & White Hospital

Sorting 1 by

Accepting patients

SUCCESSOR-2

A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
Learn more
  • CELMoD
  • Randomization
  • Phase 3